JP2016124574A - Polyvinyl chloride sheet for medicine packaging - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a polyvinyl chloride sheet for medicine packaging having less odors while maintaining stability, such as thermal stability, at a similar level to the conventional art.SOLUTION: A polyvinyl chloride sheet for medicine packaging comprises a compound (I) represented by the following formula (I) or a tautomer thereof.SELECTED DRAWING: None

Description

  The present invention relates to a polyvinyl chloride sheet for pharmaceutical packaging.

  Conventionally, a polyvinyl chloride (PVC) sheet or the like has been used as a packaging sheet for pharmaceuticals, and this PVC sheet is mainly used for a pharmaceutical packaging sheet in the market.

Since PVC tends to be discolored easily by heat at the time of molding and the like, a stabilizer has been conventionally used in the PVC sheet to prevent this discoloration. Stabilizers are known (for example, Patent Document 1).
Many of the PVC sheets for pharmaceutical packaging used in the current market are sheets containing a tin-based stabilizer such as dioctyltin.

In addition to safety, these pharmaceutical packaging sheets have various properties (low oxygen permeability, moisture resistance, UV-cutting properties, etc.) depending on the properties of the contents in addition to formability and transparency. ) Etc. are required.
In particular, a sheet used for an application that requires delicate handling in the case of a pharmaceutical product, for example, if the sheet has an odor, the pharmaceutical product may have a problem with the properties of the pharmaceutical product itself packaged with the sheet. Since there may be doubts about the user, there is a demand for low odor.

Japanese Patent Laid-Open No. 06-270930

  However, the conventional polyvinyl chloride sheet for pharmaceutical packaging has a peculiar odor. In addition, when forming a blister pack from a conventional polyvinyl chloride sheet for packaging pharmaceutical products, it is necessary to apply heat or the like. However, at this time, odor is likely to occur, and the blister pack creator's hygiene and work From the environmental aspect, it was necessary to suppress the generation of odor. Further, the formed blister pack easily has odor remaining in the pocket due to its shape, and medicines are accommodated in the pocket. Therefore, it is necessary to reduce the odor remaining in the pocket.

  The present invention has been made in view of the above problems, and it is an object of the present invention to provide a polyvinyl chloride-based sheet for pharmaceutical packaging with less odor while maintaining stability such as thermal stability comparable to conventional ones. To do.

As a result of intensive studies to solve the above problems, the present inventors have found that the above problems can be solved by using a polyvinyl chloride sheet for pharmaceutical packaging containing a specific compound, and the present invention has been completed. It was.
A configuration example of the present invention is as follows.

  [1] A polyvinyl chloride sheet for pharmaceutical packaging, comprising the compound (I) represented by the following formula (I) or a tautomer thereof.

（式（Ｉ）中、Ｒ¹およびＲ³はそれぞれ独立に、炭素数６〜１８のアリール基、炭素数１〜１８のアルキル基、炭素数７〜１８のアラルキル基、アルキル基の少なくとも１部がハロゲン原子または酸素原子で置換された基（但し、該基の炭素数は１〜１８である。）、ヒドロキシ基、または、アリール基の少なくとも１部がアルコキシ基で置換された基（但し、該基の炭素数は７〜１８である。）であり、Ｒ²は、単結合、炭素数１〜１８のアルキレン基または炭素数７〜１８のアラルキレン基であり、Ｒ¹〜Ｒ³は互いに結合していてもよく、Ｒ²において２量体を形成してもよい。）

(In the formula (I), R ¹ and R ³ are each independently at least part of an aryl group having 6 to 18 carbon atoms, an alkyl group having 1 to 18 carbon atoms, an aralkyl group having 7 to 18 carbon atoms, and an alkyl group. Is a group substituted with a halogen atom or an oxygen atom (provided that the group has 1 to 18 carbon atoms), a hydroxy group, or a group wherein at least part of the aryl group is substituted with an alkoxy group (provided that The group has 7 to 18 carbon atoms.), R ² is a single bond, an alkylene group having 1 to 18 carbon atoms or an aralkylene group having 7 to 18 carbon atoms, and R ^{1 to} R ³ are It may be bonded, and a dimer may be formed in R ^2. )

  [2] The polyvinyl chloride for pharmaceutical packaging according to [1], wherein the content of the compound (I) or a tautomer thereof is 0.01 to 2.0 parts by mass with respect to 100 parts by mass of the vinyl chloride resin. System sheet.

  [3] The polyvinyl chloride sheet for packaging pharmaceuticals according to [1] or [2], which is a sheet for blister packs for packaging pharmaceuticals.

  According to the present invention, not only is it excellent in safety, it is made of a low toxicity material while maintaining the stability such as the thermal stability of the conventional level, and is excellent in ultraviolet cutting ability and transparency. It is possible to provide a polyvinyl chloride sheet for pharmaceutical packaging with less odor. In addition, by using the polyvinyl chloride sheet for pharmaceutical packaging of the present invention, even when heat is applied to form a blister pack, it is difficult for odor to occur and odor residue in the pocket hardly occurs. It is possible to provide a blister pack that is excellent in terms of hygiene and work environment of the blister pack creator, and that is less likely to cause doubts and unpleasant feelings about the drug for the drug user. Furthermore, according to the polyvinyl chloride sheet for pharmaceutical packaging of the present invention, a blister pack can be formed at a low temperature.

FIG. 1 is a diagram showing a total light transmission curve of resin sheets obtained in Example 1 and Comparative Example 1. FIG.

≪Polyvinyl chloride sheet for pharmaceutical packaging≫
The polyvinyl chloride sheet for pharmaceutical packaging of the present invention (hereinafter also simply referred to as “PVC sheet”) is a compound (I) represented by the following formula (I) or a tautomer thereof (hereinafter referred to as compound (I)). And tautomers thereof are also referred to as “compound (A)”. Specifically, it includes compound (A) and vinyl chloride resin (B).

<Compound (A)>
Conventional polyvinyl chloride sheets for packaging pharmaceutical products have a characteristic odor. As a result of intensive studies by the inventor to reduce this odor, it has been confirmed that a conventionally used stabilizer, particularly a tin-based stabilizer, contributes to the odor of a polyvinyl chloride sheet for pharmaceutical packaging. discovered. Therefore, the present inventor has conducted intensive experiments and uses the compound (A), so that the conventional stabilizer has the same level of stability as or superior to the deterioration of vinyl chloride resin due to heat. It has been found that a PVC sheet having a low odor can be obtained while having the above-described stability, and further, a PVC sheet excellent in ultraviolet cutting ability and transparency can be obtained.
Of course, the present inventor has not only found these things, but also has confirmed that there is no problem in safety even when the compound (A) is used, and that it can be used for packaging pharmaceutical products.

In addition, tin-based stabilizers have been used because they exhibit excellent effects on the thermal stability of PVC and are inexpensive, but in recent years their toxicity has been discovered and their usage will be limited in the future. there is a possibility.
However, when a pharmaceutical product is put on the market, it is necessary to obtain an application for approval of the pharmaceutical product. In this case, it is necessary to receive an application for approval together with the packaging material of the pharmaceutical product. Due to the high amount of money, there has been no change in the pharmaceutical packaging sheet currently used in the market in the current situation where there is no particular problem even if a tin stabilizer is included.
Therefore, compound (A) is used in place of the tin-based stabilizer, and safety, low odor, and UV-cutting ability are as good as or better than when the tin-based stabilizer is used. In addition, the PVC sheet of the present invention having excellent transparency is useful industrially, particularly in the pharmaceutical packaging field. That is, in the present invention, it is preferable not to use a tin-based stabilizer.

The compound (A) is used as a stabilizer for the vinyl chloride resin (B) contained in the PVC sheet of the present invention, specifically, a low odor resin for a polyvinyl chloride sheet for pharmaceutical packaging. Used as a stabilizer.
By using such a compound (A), low toxicity while maintaining stability such as thermal stability equivalent to or higher than that of the conventional one without using a tin-based stabilizer that has been conventionally used. In particular, it is possible to obtain a polyvinyl chloride sheet for pharmaceutical packaging which has a low odor and is excellent in ultraviolet ray cutting ability, visible light permeability and transparency.
Furthermore, the PVC sheet which can form a blister pack at low temperature can be obtained by using such a compound (A).

  Ketones are one type of compounds that usually cause unpleasant odors, but the reason is not clear in the present invention, but the odor of the resin sheet can be reduced even if such ketones are used.

In the formula (I), R ¹ and R ³ are each independently at least part of an aryl group having 6 to 18 carbon atoms, an alkyl group having 1 to 18 carbon atoms, an aralkyl group having 7 to 18 carbon atoms, and an alkyl group. Is a group substituted with a halogen atom or an oxygen atom (provided that the group has 1 to 18 carbon atoms), a hydroxy group, or a group wherein at least part of the aryl group is substituted with an alkoxy group (provided that The group has 7 to 18 carbon atoms).

  The aryl group having 6 to 18 carbon atoms is preferably an aryl group having 6 to 12 carbon atoms, and examples thereof include a phenyl group, a biphenyl group, and a naphthyl group.

  As said C1-C18 alkyl group, a C1-C12 alkyl group is preferable, and a methyl group, an ethyl group, n-propyl group, isopropyl group, n-butyl group, sec-butyl group, tert-butyl. Group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group and the like.

  The aralkyl group having 7 to 18 carbon atoms is preferably an aralkyl group having 7 to 12 carbon atoms, and examples thereof include a benzyl group, a phenylmethyl group, and a phenylethyl group.

The group in which at least a part of the alkyl group is substituted with a halogen atom or an oxygen atom (provided that the group has 1 to 18 carbon atoms) is preferably a group having 1 to 12 carbon atoms. Examples include groups in which at least a part is substituted with a group such as a hydroxy group, a carboxyl group, or an acyl group. Specifically, —CF ₃ , —CCl ₃ , —O—CH ₃ , —O—C ₂ H ₅ , —CH ₂ COOCH ₃ , —CH ₂ COOC ₂ H _{5 and the} like.

The group in which at least a part of the aryl group is substituted with an alkoxy group (provided that the group has 7 to 18 carbon atoms) is preferably a group having 7 to 12 carbon atoms, -Ph-O-CH ₃ , -Ph-O-C ₂ H ₅ (wherein ph represents a benzene ring).

In the formula (I), R ² is a single bond, an alkylene group or an aralkylene group having 7 to 18 carbon atoms having 1 to 18 carbon atoms.

  The alkylene group having 1 to 18 carbon atoms is preferably an alkylene group having 1 to 12 carbon atoms, more preferably an alkylene group having 1 to 6 carbon atoms, a methylene group, an ethylene group, a methylmethylene group, a propylene group, or a methylethylene group. Dimethylmethylene group, butylene group, methylpropylene group, methylpropylene group and the like.

  The aralkylene group having 7 to 18 carbon atoms is preferably an aralkylene group having 7 to 12 carbon atoms, and examples thereof include a phenylmethylene group, a phenylethylene group, and a phenylpropylene group.

In the formula (I), R ^{1 to} R ³ may be bonded to each other, and R ² may form a dimer. Such compounds include cyclohexane-1,3-dione, bisacetylacetone, 5,5′-dimethylcyclohexane-1,3-dione, 2,2′-methylenebiscyclohexane-1,3-dione, 2-benzyl. And cyclohexane-1,3-dione.

Wherein the compound (I) is more excellent thermal stability and the like, from the viewpoint of the PVC sheet excellent in UV ability is obtained, R ¹ and R ³ is an aryl group having 6 to 12 carbon atoms, R ² is The compound (i) which is a C1-C6 alkylene group is preferable, Furthermore, it is excellent in a low odor, heat stability, and ultraviolet-cutting ability, and can use more suitably as a sheet | seat for pharmaceutical packaging. R ¹ and R ³ are each a phenyl group, and compound (ii) in which R ² is a methylene group is more preferred.

  Examples of the tautomer of compound (I) include isomers obtained by keto-enol tautomerism of compound (I).

  As the compound (A), a compound (I), further a compound (i), particularly a compound (ii) is particularly preferable because a PVC sheet excellent in high thermal stability, low odor, and high ultraviolet ray cutting ability can be obtained. Is preferred.

  As the compound (A), a compound synthesized by a conventionally known method may be used, or a commercially available product may be used.

In the PVC sheet of the present invention, the content of the compound (A) is preferably 0.01 to 2.0 parts by mass, more preferably 0.01 to 1. parts by mass with respect to 100 parts by mass of the vinyl chloride resin. It is 0 mass part, More preferably, it is 0.01-0.7 mass part, Most preferably, it is 0.01-0.5 mass part.
When the content of the compound (A) is in the above range, a PVC sheet excellent in balance with high thermal stability, low odor, high ultraviolet ray cutting ability and high transparency can be obtained, and particularly suitable for blister packs. PVC sheet can be obtained.

  The compound (A) contained in the PVC sheet of the present invention may be one kind alone, or two or more kinds.

<Vinyl chloride resin (B)>
The vinyl chloride resin (B) contained in the PVC sheet of the present invention is not particularly limited as long as it is a vinyl chloride resin that has been used in a conventionally known sheet for packaging pharmaceutical products.
In addition, 1 type may be sufficient as resin (B) contained in the PVC sheet of this invention, and 2 or more types may be sufficient as it.

  The vinyl chloride resin is not particularly limited as long as it is a resin obtained from vinyl chloride as a raw material, and examples thereof include a vinyl chloride homopolymer or a copolymer of vinyl chloride and other monomers.

  Although it does not specifically limit as said other monomer, For example, ethylene, propylene, acrylonitrile, vinyl acetate, maleic acid or its ester, acrylic acid or its ester, methacrylic acid or its ester, and vinylidene chloride are mentioned.

The vinyl chloride resin may be a resin in which the homopolymer or copolymer is partially crosslinked. Further, a polymer blend of a vinyl chloride resin, for example, a polymer blend composed of a vinyl chloride resin and polyvinylidene chloride may be used.
Of these, vinyl chloride homopolymers are preferred.

  The average degree of polymerization of the vinyl chloride resin measured based on JIS K 6720-2 is preferably 500 to 5000, more preferably from the viewpoint of obtaining a PVC sheet having excellent thermal stability and moldability. 500-2000.

  The resin (B) may be a resin synthesized by a conventionally known method or a commercially available product.

<Other components (C)>
The PVC sheet of the present invention may contain other components (C) other than the compound (A) and the resin (B) as necessary, as long as the effects of the present invention are not impaired.

Examples of the other component (C) include antioxidants, stabilizers such as heat stabilizers and light stabilizers, ultraviolet scattering agents, pigments, antistatic agents, lubricants, softeners, plasticizers, and processing aids. It is done.
Each of these other components (C) may be used alone for the PVC sheet of the present invention, or two or more may be used for the PVC sheet of the present invention.

Since the PVC sheet of the present invention contains the compound (A), a benzophenone ultraviolet absorber, a benzotriazole ultraviolet absorber, a salicylate ultraviolet absorber, which has been used in a conventional polyvinyl chloride sheet for pharmaceutical packaging, Even if it does not contain organic ultraviolet absorbers such as triazine-based ultraviolet absorbers and benzoate-based ultraviolet absorbers, it has a desired ultraviolet ray cutting ability. For this reason, it is preferable that the PVC sheet of this invention does not contain an organic ultraviolet absorber from the point of being able to obtain the PVC sheet which is excellent in safety and has few bleed-out components.
In addition, since the PVC sheet of the present invention contains the compound (A), when the purpose is to obtain a PVC sheet that is further excellent in safety and has few bleed-out components, the PVC sheet of the present invention contains ultraviolet rays. It is preferable not to contain an absorber or an ultraviolet scattering agent.

<Softener>
As the softening agent, a softening agent conventionally used for PVC sheets can be used, and is not particularly limited. However, from the viewpoint of improving impact resistance of the obtained PVC sheet, butyl acrylate-methyl (meta ) Acrylate copolymer, butyl acrylate-styrene-methyl (meth) acrylate copolymer, ethylene-vinyl acetate copolymer, methyl methacrylate-butadiene-styrene copolymer, acrylonitrile-butadiene-styrene copolymer, epoxy-modified ethylene -Impact resistance improving resins such as propylene copolymer, styrene-butadiene copolymer, styrene-isoprene copolymer, styrene-ethylene-butylene copolymer, and styrene-ethylene-propylene copolymer are preferred.

<Plasticizer>
As the plasticizer, plasticizers conventionally used for PVC sheets can be used, and are not particularly limited, but di-2-ethylhexyl phthalate (DOP), dibutyl phthalate (DBP), diheptyl phthalate (DHP) Phthalate plasticizers such as diisodecyl phthalate (DIDP); fatty acid ester plasticizers such as di-2-ethylhexyl adipate (DOA), diisobutyl adipate (DIBA), dibutyl adipate (DBA); epoxidized linseed oil, epoxy Epoxidized ester plasticizers such as hydrogenated soybean oil, epoxidized castor oil, epoxidized safflower oil, epoxidized flaxseed oil fatty acid butyl, octyl epoxy stearate; tri-2-ethylhexyl trimellitate (TOTM), triisononyl Trimellitate (TI Trimellitic acid ester plasticizers such as TM); trimethyl phosphate (TMP), and phosphoric acid ester-based plasticizers such as triethyl phosphate (TEP) and the like. Among these, an epoxidized ester plasticizer is preferable from the viewpoint of moldability and workability of the PVC sheet.

<Lubricant>
As the lubricant, a lubricant conventionally used for PVC sheets can be used, and is not particularly limited, and examples thereof include dimethylpolysiloxane, fatty acid alcohol ester, low molecular polyethylene, and the like. Therefore, fatty acid alcohol ester is preferable.
The fatty acid alcohol ester is preferably a 1-3-valent ester compound of glycerin and a fatty acid, for example, stearic acid monoglyceride, stearic acid diglyceride, stearic acid triglyceride lubricant, oleic acid glyceride lubricant, Examples include palmitate glyceride lubricants.

<Processing aid>
As the processing aid, processing aids conventionally used for PVC sheets can be used, and are not particularly limited, but acrylic processing such as methyl methacrylate / ethyl acrylate copolymer, high molecular weight polymethyl methacrylate, etc. Auxiliaries are preferred.

<Stabilizer>
As the stabilizer, a stabilizer conventionally used for PVC sheets can be used, and is not particularly limited, but is not limited to metal compounds such as lithium, sodium, potassium, magnesium, calcium, aluminum, barium, and zinc; Metallic compounds such as calcium, barium, zinc, etc. from the point of obtaining a PVC sheet excellent in safety and stability, such as phosphate esters, polyhydric alcohols, phenolic compounds, epoxy compounds, and organic phosphite compounds. Is preferred.

<Physical properties of PVC sheet>
The shape of the PVC sheet of the present invention is not particularly limited, and may be appropriately selected according to a desired application.
The thickness of the PVC sheet of the present invention is not particularly limited, but is preferably 30 to 500 μm, more preferably 50 to 300 μm, from the viewpoint of moldability to a blister pack.

The odor of the PVC sheet of the present invention is preferably 15 ppc or less, more preferably 10 ppc or less.
The odor is obtained by cutting out a 2.0 g test piece from the PVC sheet of the present invention, sealing the test piece in a container with a capacity of 22 mL, heating it at 140 ° C. for 5 minutes, and removing 600 μL of the gas generated by heating. When measured by GC / MS, the total ratio of the peak areas of all the generated gas components from the test piece when the peak area of air is taken as 100 is shown, and specifically, measured by the method described in the following examples can do.
A PVC sheet having an odor amount within the above range is a sheet having a considerably improved odor compared to a conventional polyvinyl chloride sheet for packaging pharmaceuticals. Such a PVC sheet is particularly preferably used for packaging pharmaceuticals. be able to.

When the thickness of the PVC sheet of the present invention is 250 μm, the maximum value of the transmittance of light having a wavelength of 220 to 380 nm measured using a spectrophotometer is preferably 10% or less, more preferably 5% or less. It is. Specifically, the maximum value of the transmittance of light having a wavelength of 220 to 380 nm can be measured by the method described in Examples below.
Some pharmaceuticals change the efficacy of the pharmaceuticals by light, particularly ultraviolet rays, and polyvinyl chloride sheets for pharmaceutical packaging are required to have high ultraviolet-cutting ability, but the transmittance is The PVC sheet in the range is excellent in ultraviolet ray cutting ability, and can be particularly suitably used for packaging pharmaceutical products.

YI value measured using a spectrocolorimeter (CM-2600d, manufactured by Konica Minolta Co., Ltd.) when the PVC sheet (thickness 250 μm) of the present invention was heated and pressurized at a temperature of 230 ° C. and a pressure of 100 kgf ( The yellow index) is preferably 20 or less, more preferably 14 or less. Specifically, the YI value can be measured by the method described in the Examples below.
A PVC sheet having a YI value in the above range is excellent in stability, particularly thermal stability, and can be particularly suitably used for packaging pharmaceutical products.

<Method for producing PVC sheet>
The PVC sheet of the present invention is formed by molding a resin composition containing the compound (A), the resin (B) and, if necessary, other components (C) into a sheet shape by a known technique such as a melt molding method. Can be manufactured.

<Multilayer sheet>
The PVC sheet of the present invention may be used as a single layer of the sheet, but if necessary, on one or both sides of the PVC sheet of the present invention, a gas barrier layer such as an oxygen barrier layer, a gas absorption layer, a moisture-proof layer, a light shielding layer. You may use as a multilayer sheet in which layers, such as a layer and a bleed-out prevention layer, were laminated.

  The multilayer sheet can be produced by a method similar to a conventionally known laminate production method. For example, the multilayer sheet is heat-bonded after the sheets forming the respective layers are superposed on one or both sides of the PVC sheet of the present invention, or the sheets forming the respective layers are bonded via an adhesive layer, etc. It can be manufactured by sticking. Here, in order to improve the interlayer adhesion of the resulting multilayer sheet, the surface of any layer forming the multilayer sheet is pretreated with corona treatment, low temperature plasma treatment, ion bombardment treatment, chemical treatment, solvent treatment, etc. You may pre-process by the method of.

  The multilayer sheet uses a resin composition containing the compound (A), the resin (B) and, if necessary, another component (C), and a composition for forming the layers, and a multilayer T-die method. It can also be manufactured by co-extrusion molding methods such as pulverization and multilayer inflation methods, extrusion coating, dry lamination, heat lamination, casting methods such as wet casting methods and dry casting methods, and general multilayer sheet molding methods such as calendar methods. it can.

  The thickness of the multilayer sheet may be appropriately selected depending on the desired application, but is usually in the range of 150 μm to 500 μm, preferably 180 μm to 350 μm. With such a thickness, a blister pack can be produced from the multilayer sheet with good moldability.

<Blister pack>
Since the PVC sheet of the present invention is excellent in stability such as thermal stability, and is excellent in moldability at low temperature, a blister pack can be easily formed. Therefore, by using the PVC sheet of the present invention, it is possible to easily obtain a blister pack having a low production cost when producing a blister pack and excellent transparency. In addition, since the blister pack can be molded at a low temperature, it is possible to suppress the generation of odors and film performance that are likely to occur during high temperature molding.

  A method for producing a blister pack from the PVC sheet of the present invention or the multilayer sheet is not particularly limited. For example, a pocket is formed by a known molding method, a medicine is loaded into each pocket, and the loaded medicine is sealed. As described above, a blister pack can be produced by bonding the PVC sheet of the present invention or the multilayer sheet and a sealing material (lid material).

Here, the method of forming a pocket in the PVC sheet of the present invention or the multilayer sheet specifically includes the following methods.
・ Heat and pressure forming method: The PVC sheet of the present invention or the multilayer sheet is sandwiched between a lower mold having holes to which high-temperature and high-pressure air is supplied and an upper mold having pocket-shaped recesses, and heated and softened. A method of forming pockets by supplying air while a preheater flat plate pressure forming method: a lower mold having holes for supplying high-pressure air after heating and softening the PVC sheet of the present invention or the multilayer sheet. And the upper mold having a pocket-shaped recess and supplying air to form a pocket. Drum-type vacuum forming method: The PVC sheet of the present invention or the multilayer sheet has a pocket-shaped recess. A method of forming a pocket by vacuuming the recess after partially heating and softening with a heating drum ・ Pin forming method: The PVC sheet of the present invention or the multilayer sheet was heated and softened , A method of pressure bonding with a pocket-shaped concavo-convex mold ・ Preheater plug-assisted pressure forming method: a lower mold having holes to which high-pressure air is supplied after the PVC sheet of the present invention or the multilayer sheet is heated and softened And an upper mold having a pocket-shaped recess, and a method of forming a pocket by supplying air and assisting the molding by raising and lowering the convex plug during molding .

  Among these, the PVC sheet of the present invention and the multilayer sheet do not cause molding defects not only by the vacuum forming method, but also by the pressure forming method. Therefore, the pressure forming such as the flat plate pressure forming method and the plug assist pressure forming method. It can be molded by the method.

  In addition, the shape, size, depth, number, arrangement, etc. of the pocket portion of the blister pack can be appropriately selected depending on the shape and use of the pharmaceutical product.

  As the sealing material (lid material), a material having a heat-sealable resin layer is preferable because the loaded contents can be sealed by heat sealing (heating adhesion). The heat-sealable resin layer is not particularly limited as long as it is a layer fused with the PVC sheet of the present invention loaded with a pharmaceutical product or the multilayer sheet at the time of heat-sealing. For example, low-density polyethylene (LDPE) , Medium density polyethylene (MDPE), high density polyethylene (HDPE), linear low density polyethylene (LLDPE), ethylene vinyl acetate copolymer (EVA), polypropylene (PP), ethylene / acrylic acid copolymer (EAA), Ethylene / methacrylic acid copolymer (EMA), ethylene / methyl acrylate copolymer (EMAA), ethylene / ethyl acrylate copolymer (EEA), ethylene / methyl methacrylic acid copolymer (EMMA), ionomer (IO) ) And the like are included.

  Moreover, it is preferable that a sealing material (cover material) has metal vapor deposition film layers, such as an aluminum layer, and a metal foil layer from the point that gas-barrier property is favorable.

  EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated more concretely, this invention is not limited by these. The resin sheets of the following examples and comparative examples are the vinyl chloride resin (B), the compound (A), or the other stabilizer (C) that has been conventionally used in PVC sheets in addition to the tin stabilizer. In particular, among these, it can manufacture using a preferable component.

[Example 1]
Polyvinyl chloride 85.6% by weight, impact resistance improving resin 8% by weight, plasticizer 4% by weight, lubricant 1% by weight, processing aid 0.6% by weight, stabilizer 0.5% by weight and dibenzoylmethane 0 The resin composition was obtained by mixing 3 mass%. Using the obtained resin composition, a resin sheet having a thickness of about 250 μm was prepared by calendar molding.

[Example 2]
In Example 1, a resin sheet was prepared in the same manner as in Example 1 except that the calendering conditions were changed so that the thickness of the obtained resin sheet was about 200 μm.

[Comparative Example 1]
In Example 1, a resin sheet having a thickness of about 250 μm was prepared in the same manner as in Example 1 except that 0.3% by mass of dioctyltin was used instead of 0.3% by mass of dibenzoylmethane.

[Comparative Example 2]
In Comparative Example 1, a resin sheet was prepared in the same manner as in Comparative Example 1, except that the calendering conditions were changed so that the thickness of the resulting resin sheet was about 200 μm.

<Stability>
The thermal stability of the resin sheets of Example 1 and Comparative Example 1 was measured by the following method. The results are shown in Table 1.
Using a hot press machine, the resin sheets of Example 1 and Comparative Example 1 were heated and pressed for 3 minutes under the conditions of a heating temperature of 220 to 260 ° C. and a pressing pressure of 100 kgf, and the state of the pressed sheet was visually confirmed. The case where there was no deformation or discoloration before and after hot pressing was evaluated as “◯”, and the case where discoloration occurred was evaluated as “x”.
Thereafter, the YI value of the sheet after hot pressing was measured using a spectrocolorimeter (Konica Minolta Co., Ltd., CM-2600d).

  Table 1 shows that the resin sheet of an Example shows the heat resistance of the same level or more compared with the conventional resin sheet (resin sheet of a comparative example).

<Odor>
The odors of the resin sheets of Example 2 and Comparative Example 2 were measured by the following method.
From each of the resin sheets of Example 2 and Comparative Example 2, 2.0 g test pieces were cut out, and the test pieces were sealed in gas chromatography vials made by PerkinElmer, each having a capacity of 22 mL. The sample was heated with a space sampler (HSS) at 140 ° C. for 5 minutes, and 600 μL of the gas generated by the heating was automatically injected into the GC / MS, and the gas generated from each specimen was analyzed. The analysis conditions for GC / MS (gas chromatography mass spectrometry) are as shown in Table 2 below.

  The results of the odor test are shown in Table 3. In Table 3, the numerical value in the left column of each test indicates the peak area of each gas component, and the numerical value in the right column indicates the ratio (%) of each generated gas component when the peak area of air is 100%. . ● and ▲ are substances with high odor intensity, and ● (organic acid) is about 100 times stronger than ▲ (aromatics, etc.).

From the resin sheets of Example 2 and Comparative Example 2, no sulfur compounds such as hydrogen sulfide, methyl sulfide, and mercaptan with strong odor intensity were detected.
From the resin sheet of Comparative Example 2, 2-Ethyl-hexanoic acid and 2-Propyl-1-pentanol were detected as substances having strong odor intensity. However, 2-Ethyl-hexanoic acid was detected from the resin sheet of Example 2. It was not detected, the amount of 2-Propyl-1-pentanol generated was reduced to 1/3 or less, and the total amount of gas generated was also reduced to 10 ppc or less.
From the above analysis results, it can be seen that the resin sheet of the example generates less odor than the conventional resin sheet (resin sheet of the comparative example).

<Ultraviolet / visible light transmission>
The total light transmittance of the resin sheets of Example 1 and Comparative Example 1 was measured using an ultraviolet-visible spectrophotometer (V-560 manufactured by JASCO Corporation). Specifically, test pieces each having a size of 10 × 40 mm were cut out from the resin sheets of Example 1 and Comparative Example 1, and the test pieces were used to emit light having a wavelength of 220 to 780 nm with the ultraviolet-visible spectrophotometer. The transmittance was measured. The results are shown in FIG.

  From FIG. 1, the resin sheet of an Example has fully cut | disconnected ultraviolet-ray (220-380 nm) compared with the conventional resin sheet (resin sheet of a comparative example), and also visible-light (400-780 nm) transmittance | permeability. It is understood that it is excellent.

<Haze>
The haze of the resin sheets of Example 1 and Comparative Example 1 was measured using an ultraviolet-visible spectrophotometer (V-560 manufactured by JASCO Corporation). Specifically, test pieces each having a size of 10 × 40 mm were cut out from the resin sheets of Example 1 and Comparative Example 1, and the total light transmittance and diffusion were measured with the UV-visible spectrophotometer using the test pieces. The light transmittance was measured, and the haze was calculated from these values.

The haze of the resin sheet of Example 1 was about 0.8%, and the haze of the resin sheet of Comparative Example 1 was about 1.5%.
From the above results, it can be seen that the resin sheet of the example has a small haze value and excellent transparency as compared with the conventional resin sheet (resin sheet of the comparative example).

<Safety>
The safety of the resin sheet of Example 1 is determined based on the standard D of food and additives (Ministry of Health and Welfare Notification No. 370 of 1959), 3D-2, synthetic resin equipment or container packaging (category: operating temperature) , 100 ° C. or less).
The resin sheet of an Example becomes an analysis result shown in Table 4, and it turns out that it is excellent in safety. In addition, the resin sheet of the example has an evaporation residue amount of 10 μg / ml in the case of using any of the heptane, 20% ethanol, water or 4% acetic acid leaching solutions as the leaching solution. The following shows that the amount of bleed out is extremely small.

Only after the safety analysis test shown in Table 4 is it determined whether or not the resin sheet can be used for packaging pharmaceutical products. Sheets for packaging pharmaceutical products are required to be safe.
Conventionally, a resin sheet containing the compound (A) and usable for packaging pharmaceutical products has not been known.

<Blister pack formability>
The blister pack moldability of the resin sheets obtained in Example 1 and Comparative Example 1 was evaluated by the following method. The results are shown in Table 5.
The moldability of the blister pack was measured using the resin sheet of Example 1 and Comparative Example 1 in a PTP molding machine (manufactured by CKD Corporation, FBP-M2) by using a pinpoint heating plate as shown in Table 5 below. After heating at Φ11.0 × H4.0 tablet mold (diameter 11 mmφ, depth 4.0 mm) and a plug assist mechanism, the resulting resin sheet mold at each temperature (tablet mold) The mold following ability was evaluated. In addition, the mold followability evaluated the external appearance nonuniformity of the pocket top part, the corner part, and the side part by visual observation.

  Further, the resin sheet having the pocket portion obtained at the above (heating temperature 120 ° C.) is sealed with aluminum foil, and after slitting the obtained blister pack, it is punched into a width 50 mm, a length 108 mm, and a corner R 5 mm. It was. The appearance of the resulting molded product was evaluated for the appearance of the die, which is the bonded portion between the aluminum foil and the resin sheet.

From Table 5, it turns out that the resin sheet of an Example can be shape | molded at low temperature compared with the conventional resin sheet (resin sheet of a comparative example), and is excellent in low temperature moldability.
In addition, it can be seen that the aluminum sealability is comparable to that of the conventional resin sheet (the resin sheet of the comparative example) without the appearance of the die and the tearing of the aluminum foil.

Claims (3)

A polyvinyl chloride-based sheet for pharmaceutical packaging, comprising the compound (I) represented by the following formula (I) or a tautomer thereof.

(In the formula (I), R ¹ and R ³ are each independently at least part of an aryl group having 6 to 18 carbon atoms, an alkyl group having 1 to 18 carbon atoms, an aralkyl group having 7 to 18 carbon atoms, and an alkyl group. Is a group substituted with a halogen atom or an oxygen atom (provided that the group has 1 to 18 carbon atoms), a hydroxy group, or a group wherein at least part of the aryl group is substituted with an alkoxy group (provided that The group has 7 to 18 carbon atoms.), R ² is a single bond, an alkylene group having 1 to 18 carbon atoms or an aralkylene group having 7 to 18 carbon atoms, and R ^{1 to} R ³ are It may be bonded, and a dimer may be formed in R ^2. )   The polyvinyl chloride sheet for pharmaceutical packaging according to claim 1, wherein the content of the compound (I) or a tautomer thereof is 0.01 to 2.0 parts by mass with respect to 100 parts by mass of the vinyl chloride resin.   The polyvinyl chloride sheet for packaging pharmaceuticals according to claim 1 or 2, which is a sheet for blister packs for packaging pharmaceuticals.

Images